A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

200990 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Vaccine

Volume 27, Issue 28, pp. 3744-3753

Field-Weighted Citation Impact: 2.78